Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Dosage adjustments of biological and related drugs for lung cancer

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: MORGADO, Manuel (University of Beira Interior, Health Science Faculty)
  • Co-author(s): Cláudia Loureiro: Health Science Faculty, University of Beira Interior, Covilhã, Portugal
    Diana Lopes: Health Science Faculty, University of Beira Interior, Covilhã, Portugal
    Ema Paulino: Portuguese Pharmaceutical Society, Lisbon, Portugal
    Manuel Morgado: Health Science Faculty, University of Beira Interior, Covilhã, Portugal;Higher School of Health, Polytechnic Institute of Guarda, Guarda, Portugal;Pharmaceutical Services, Hospital Centre of Cova da Beira, Covilhã, Portugal
  • Abstract:

    Background

    Lung cancer is cancer with highest mortality rate in Portugal. In the last years, the pharmaceutical industry has developed new biological drugs for this type of cancer. It is important to understand which dosage adjustments are required in patients with comorbid renal or hepatic impairment for effective and safe therapy.

    Methods

    The human

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses